Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Influence Of Steroid Exposure On CMV Specific T Cells Following Allogeneic Stem Cell Transplantation

Cornelia S. Link, MD, Elke Rücker-Braun, PhD, Sebastian Tuve, MD, Sarah Matko, Marc Schmitz, MD, Rebekka Wehner, PhD, Antje Tunger, Katja Sockel, MD, Stefani Parmentier, MD, Jan Moritz Middeke, MD, Änne Boldt, MD, Johannes Schetelig, MD, M. Sc,, Markus Odendahl, PhD, Torsten Tonn, MD, Martin Bornhäuser, MD, Falk Heidenreich, PhD

Blood (2013) 122 (21): 5488.

https://doi.org/10.1182/blood.V122.21.5488.5488

Published: 2013

Journal Articles

A Distinct Immunophenotypic Profile Of Del(5q) MDS Allows For Fast Monitoring Of Response To Treatment With Lenalidomide Or Azacitidine

Uta Oelschlaegel, PhD, Brigitte Mohr, PhD, Michael Kramer, PhD, Stefani Parmentier, MD, Katja Sockel, MD, Christian Thiede, MD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Uwe Platzbecker, MD, PhD

Blood (2013) 122 (21): 2780.

https://doi.org/10.1182/blood.V122.21.2780.2780

Published: 2013

Journal Articles

Response and Long-Term Outcome After Treatment With Third-Party Mesenchymal Stromal Cells - Updated Results In 58 Patients With Steroid-Refractory Acute Graft-Versus Host Disease -

Felix von Dalowski, Michael Kramer, PhD, Martin Wermke, MD, Christoph Röllig, MD, Nael Alakel, MD, Friedrich Stölzel, MD, Stefani Parmentier, MD, Katja Sockel, MD, Mathias Krech, PhD, Marc Schmitz, MD, Uwe Platzbecker, MD, PhD, Johannes Schetelig, MD, M. Sc, Martin Bornhauser, MD, Malte von Bonin, MD

Blood (2013) 122 (21): 4612.

https://doi.org/10.1182/blood.V122.21.4612.4612

Published: 2013

Journal Articles

Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML – Results Of The Bridge Trial –

Blood (2013) 122 (21): 304.

https://doi.org/10.1182/blood.V122.21.304.304

Published: 2013

Journal Articles

Bone marrow metastases by alveolar rhabdomyosarcoma in a 31-year-old patient

Stefani Parmentier, Stephan Richter

Blood (2013) 122 (12): 2000.

https://doi.org/10.1182/blood-2013-04-494864

Published: 2013

Journal Articles

Acute Erythroleukemia Morphology Does Not Confer an Unfavourable Prognosis in Itself. Results of a Subgroup Analysis of the Prospective Randomized AML96-, AML2003 and AML60+ Studies of the Study Alliance Leukemia (SAL)

Stefani Parmentier, MD, Michael Kramer, Katharina Koch, Brigitte Mohr, PhD, Christian Klesse, Christian Thiede, Christoph Röllig, Mathias Hänel, MD, Norbert Schmitz, MD, Kerstin Schäfer-Eckart, Walter E. Aulitzky, Wolfgang E. Berdel, MD, Hubert Serve, Prof. Dr. med., Stefan W. Krause, Jiri Mayer, MD, Martin Bornhäuser, MD, Gerhard Ehninger, Markus Schaich, MD

Blood (2012) 120 (21): 1481.

https://doi.org/10.1182/blood.V120.21.1481.1481

Published: 2012

Journal Articles

Sorafenib Versus Placebo in Addition to Standard Therapy in Adult Patients ≥60 Years with Newly Diagnosed Acute Myeloid Leukemia: Results From the Randomized-Controlled Soraml Trial

Blood (2012) 120 (21): 144.

https://doi.org/10.1182/blood.V120.21.144.144

Published: 2012

Journal Articles

Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML – Interim Results of the Bridge Trial

Jan Moritz Middeke, MD, Stefani Parmentier, MD, Nael Alakel, MD, Markus Schaich, MD, Christian Thiede, Uwe Platzbecker, MD, Christoph Röllig, Mathias Hänel, MD, Gernot Stuhler, MD, Anke Morgner, MD, Uta Eulenstein, Gerhard Ehninger, Martin Bornhäuser, MD, Johannes Schetelig, MD

Blood (2012) 120 (21): 2017.

https://doi.org/10.1182/blood.V120.21.2017.2017

Published: 2012

Journal Articles

A Unique Case of a Donor Cell Acute Myeloid Leukemia Reveals Complex Kinetics of Mutations and Evolution of the Disease

Sylvia Herold, PhD, Matthias Kuhn, Uwe Platzbecker, MD, Stange Thoralf, Jörgen Radke, MD, Caroline Heiderich, Lange Thoralf, MD, Kerstin Gutsche, MD, Johannes Schetelig, Stefani Parmentier, MD, Brigitte Mohr, PhD, Markus Schaich, MD, Hubert Serve, Prof. Dr. med., Christian H. Brandts, Martin Bornhäuser, Gerhard Ehninger, Christian Thiede

Blood (2012) 120 (21): 886.

https://doi.org/10.1182/blood.V120.21.886.886

Published: 2012

Journal Articles

Pseudo-Auer rods in a patient with newly diagnosed IgG myeloma

Stefani Parmentier, Joergen Radke

Blood (2012) 119 (3): 650.

https://doi.org/10.1182/blood-2010-12-326884

Published: 2012

Journal Articles

Focal Positivity for Non-Specific Esterase in AML: A Surrogate Marker to Predict AML with t(8;21)/ RUNX1-RUNX1T1

Stefani Parmentier, MD, Nicole Birninger, Uta Oelschlägel, Brigitte Mohr, Markus Schaich, MD, Frank Kroschinsky, MD, Christian Thiede, MD, Gerhard Ehninger, MD

Blood (2011) 118 (21): 2534.

https://doi.org/10.1182/blood.V118.21.2534.2534

Published: 2011

Journal Articles

No Benefit of Combining Additional Compounds with Standard High Dose Cytarabine Consolidation: Results of the Prospective Randomized AML2003 Study

Blood (2011) 118 (21): 255.

https://doi.org/10.1182/blood.V118.21.255.255

Published: 2011

Journal Articles

Pernicious Anemia Mimicking MDS by Del(3p) in Cytogenetics and Monocytic Leukemia in Trephine Biopsy by Highly Expression of CD163 Positive Cells

Stefani Parmentier, MD, Jörg Meinel, Christiane Jakob, MD, Anke Frömmel, MD, Brigitte Mohr, Gerhard Ehninger, MD, Markus Schaich, MD, Uwe Platzbecker, MD

Blood (2011) 118 (21): 5038.

https://doi.org/10.1182/blood.V118.21.5038.5038

Published: 2011

Journal Articles

The HCT-Specific Comorbidity Index Fails to Predict Survival After Allogeneic HCT In High Risk AML Patients - A Single Center Experience

Nicole Birninger, Martin Bornhäuser, Martin Wermke, Stefani Parmentier, Brigitte Mohr, Christoph Röllig, Uwe Platzbecker, Gerhard Ehninger, Johannes Schetelig

Blood (2010) 116 (21): 1326.

https://doi.org/10.1182/blood.V116.21.1326.1326

Published: 2010

Journal Articles

Dysmyelopoiesis In Healthy Bone Marrow Donors

Stefani Parmentier, MD, Kerstin Lorenz, Michael Kramer, Ulrich Schuler, MD, Rainer Ordemann, MD, Johannes Schetelig, MD, Gerhard Ehninger, MD, Frank Kroschinsky, MD

Blood (2010) 116 (21): 4006.

https://doi.org/10.1182/blood.V116.21.4006.4006

Published: 2010

Journal Articles

A Rapid Flow Cytometric Method for the Detection of NPM1 Mutated Patients with Acute Myeloid Leukemia (AML).

Uta Oelschlaegel, PhD, Sina Koch, PhD, Markus Schaich, MD, Frank Kroschinsky, MD, Stefani Parmentier, MD, Gerhard Ehninger, MD, Christian Thiede, MD

Blood (2008) 112 (11): 1490.

https://doi.org/10.1182/blood.V112.11.1490.1490

Published: 2008

NARROW

Influence Of Steroid Exposure On CMV Specific T Cells Following Allogeneic Stem Cell Transplantation

A Distinct Immunophenotypic Profile Of Del(5q) MDS Allows For Fast Monitoring Of Response To Treatment With Lenalidomide Or Azacitidine

Response and Long-Term Outcome After Treatment With Third-Party Mesenchymal Stromal Cells - Updated Results In 58 Patients With Steroid-Refractory Acute Graft-Versus Host Disease -

Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML – Results Of The Bridge Trial –

Bone marrow metastases by alveolar rhabdomyosarcoma in a 31-year-old patient

Acute Erythroleukemia Morphology Does Not Confer an Unfavourable Prognosis in Itself. Results of a Subgroup Analysis of the Prospective Randomized AML96-, AML2003 and AML60+ Studies of the Study Alliance Leukemia (SAL)

Sorafenib Versus Placebo in Addition to Standard Therapy in Adult Patients ≥60 Years with Newly Diagnosed Acute Myeloid Leukemia: Results From the Randomized-Controlled Soraml Trial

Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML – Interim Results of the Bridge Trial

A Unique Case of a Donor Cell Acute Myeloid Leukemia Reveals Complex Kinetics of Mutations and Evolution of the Disease

Pseudo-Auer rods in a patient with newly diagnosed IgG myeloma

Focal Positivity for Non-Specific Esterase in AML: A Surrogate Marker to Predict AML with t(8;21)/ RUNX1-RUNX1T1

No Benefit of Combining Additional Compounds with Standard High Dose Cytarabine Consolidation: Results of the Prospective Randomized AML2003 Study

Pernicious Anemia Mimicking MDS by Del(3p) in Cytogenetics and Monocytic Leukemia in Trephine Biopsy by Highly Expression of CD163 Positive Cells

The HCT-Specific Comorbidity Index Fails to Predict Survival After Allogeneic HCT In High Risk AML Patients - A Single Center Experience

Dysmyelopoiesis In Healthy Bone Marrow Donors

A Rapid Flow Cytometric Method for the Detection of NPM1 Mutated Patients with Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only